MEDROL

LOE Approaching

methylprednisolone

NDAORALTABLET
Approved
Oct 1957
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

Corticosteroid Hormone Receptor Agonists

Pharmacologic Class:

Corticosteroid

Clinical Trials (5)

NCT06623370Phase 4Completed

The Effect of Methylprednisolone on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group

Started Oct 2024
NCT04016025Phase 4Completed

A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers

Started Dec 2020
80 enrolled
Adherence, PatientChronic Eczema
NCT02763761Phase 2Withdrawn

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Started Aug 2016
0
Renal Cell CarcinomaMelanomaLung Cancer
NCT02424435Phase 1Completed

Methylprednisolone Treatment of Friedreich Ataxia

Started Jun 2015
11 enrolled
Friedreich Ataxia
NCT02229422Phase 1/2Unknown

A Study of Obinutuzumab(GA101) in Combination With High-Dose Methylprednisolone(HDMP) in Chronic Lymphocytic Leukemia(CLL) Patients (GA101 & HDMP)

Started Sep 2014
40 enrolled
CLL